Index de l'article

Conclusion

 

A la lumière de ce cas clinique, des études expérimentales et de ces ECR, on peut donc considérer que l’acupuncture est une alternative séduisante aux traitements classiques. Sans effets secondaires, sans effets iatrogènes autant sur la maman que sur l’enfant alors que l’on connaît les effets indésirables associés au traitement pharmacologique des états dépressifs sur les fœtus à échéance [[77]]. Il ne serait pas déraisonnable d'utiliser l'acupuncture en tant que monothérapie dans les dépressions des femmes enceintes. Cela pourrait être une alternative raisonnable aux inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) ou de la psychothérapie. Néanmoins, il est nécessaire de réaliser de nouveaux ECR de grande puissance et grande qualité méthodologique et même de réaliser des ECR entre acupuncture et ISRS si l’éthique le permet, ceci afin de déterminer si l'acupuncture peut être considérée comme un traitement de première ligne chez les femmes enceintes. En conclusion et compte tenu de tous ces éléments, l’utilisation de l’acupuncture dans les états dépressifs chez la femme enceinte peut être proposée avec un grade B de présomption scientifique de niveau 2 de preuves selon les recommandations de la Haute Autorité de Santé française (HAS) [[78]].

 

Références

 

[1]. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. 

[2]. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.

[3]. Stéphan JM. DIU d’Acupuncture Obstétricale : tableaux d’une exposition. Canal carpien, prise en charge de la montée laiteuse, variétés occipito-postérieures et travail. Acupuncture & Moxibustion. 2013;12(3):240-245.

[4]. Fossati P. La neuroplasticité sous-corticale : impact  thérapeutique potentiel dans la dépression ? Encephale. 2006;32(Pt 2):S40-3.

[5]. Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry. 2010;9(3):155-61.

[6]. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552-62.

[7]. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009;301(23):2462-71.

[8]. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry. 1996;1(4):336-42.

[9]. Holsboer F, Ising M. Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol. 2008;583(2-3):350-7.

[10]. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56.

[11]. Schatzberg AF, Lindley S. Glucocorticoid antagonists in neuropsychiatric [corrected] disorders. Eur J Pharmacol. 2008;583:358–364.

[12]. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55-68.

[13]. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry. 2004 Aug;61(8):765-73.

[14]. Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 2006;67 Suppl 6:3-8.

[15]. Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry. 2004 Mar;161(3):564-6.

[16]. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry. 2005;66(1):85-93.

[17]. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651-60.

[18]. Fitzgerald PB, Laird AR, Maller J. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp. 2008;29:683–695.

[19]. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160(8):1516-8.

[20]. Cole J, Toga AW, Hojatkashani C, Thompson P, Costafreda SG, Cleare AJ, Williams SC, Bullmore ET, Scott JL, Mitterschiffthaler MT, Walsh ND, Donaldson C, Mirza M, Marquand A, Nosarti C, McGuffin P, Fu CH. Subregional hippocampal deformations in major depressive disorder. J Affect Disord. 2010;126(1-2):272-7.

[21]. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10(9):1089-93.

[22]. Townsend JD, Eberhart NK, Bookheimer SY, Eisenberger NI, Foland-Ross LC, Cook IA, Sugar CA, Altshuler LL. fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res. 2010;183(3):209-17.

[23]. Hasler G, van der Veen JW, Tumonis T. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64:193–200.

[24]. Birkenhäger TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol. 1995;10(3):181-95.

[25]. Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry. 2005;58(12):969-73.

[26]. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-64.

[27]. Kendell SF, Krystal JH, Sanacora G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets. 2005;9:153–168.

[28]. Deschwanden A, Hasler G. Presented at the 22nd European College of Neuropsychopharmacology Meeting. Istanbul: 2009. May, Metabotropic glutamate receptor 5: role in depression?

[29]. Boivin DB, Czeisler CA, Dijk DJ. Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry. 1997;54:145–152

[30]. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 2008;23(7):571-85.

[31]. Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. Eur Neuropsychopharmacol. 2013;23(12):1687-97.

[32]. Jenniches I, Ternes S, Albayram O, Otte DM, Bach K, Bindila L, Michel K, Lutz B, Bilkei-Gorzo A, Zimmer A. Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels. Biol Psychiatry. 2015 Apr 14. pii:S0006-3223(15)00314-5.

[33]. Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol. 2005 May;19(3):293-300.

[34]. Moreira FA, Wotjak CT. Cannabinoids and anxiety. Curr Top Behav Neurosci. 2010;2:429-50.

[35]. Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract. 2007;61(12):2030-40. 

[36]. Hélène Ollat, Sylvain Pirot . Physiopathologie de la dépression – Un trouble de la neuroplasticité ? (I) Neuropsychiatrie : Tendances et Débats 2003 ; 20 : 15-26

[37]. Palazidou E. The neurobiology of depression. Br Med Bull. 2012;101:127-45.

[38]. Stéphan JM. Acupuncture expérimentale, stress, axe neuro-endocrinien et système limbique. Acupuncture & Moxibustion. 2005;4(4):340-349.

[39]. Stéphan JM. Acupuncture expérimentale, stress et molécules informationnelles. Acupuncture & Moxibustion. 2006;5(2):162-170.

[40]. Liao YY, Seto K, Saito H, Fujita M, Kawakami M. Effects of acupuncture on adrenocortical hormone production. (II) Effect of acupuncture on the response of adrenocortical hormone production to stress. Am J Chin Med 1980;8(1-2):160-6.

[41]. Guimaraes CM, Pinge MC, Yamamura Y, Mello LE. Effects of acupuncture on behavioral, cardiovascular and hormonal responses in restraint-stressed Wistar rats. Braz J Med Biol Res 1997;30(12):1445-50.

[42]. Cui H, Xiahong L, Xuewu L et Al. [Effects of puncturing the acupoints of baihui and sanyinjiao by electric needles on the HPA axis in the rat chronic stress-induced depression model]. Journal of Beijing University of traditional chinese medecine 2001;24(3):74.

[43]. You W, Shi YJ, Han YJ, Jia BH, Tu Y. [Effect of electroacupuncture of "Baihui" (GV 20)-"Yintang" (EX-HN 3) on the expression of glucocorticoid and glucocorticoid receptor mRNA of the chronic stress model rats]. Zhen Ci Yan Jiu. 2010;35(4):261-6.

[44]. Zhu LT, Tian ZZ. [Effect of electroacupuncture intervention on expression of corticotropin-releasing factor protein in hypothalamus and hippocampus of traumatized rats]. Zhen Ci Yan Jiu. 2013 Oct;38(5):369-74.

[45]. Cheng XD, Wu GC, He QZ, Cao XD. Effect of continued electroacupuncture on induction of interleukin-2 production of spleen lymphocytes from the injured rats. Acupunct Electrother Res 1997;22(1):1-8.

[46]. Du LN, Jiang JW, Wu GC, Cao XD. Naloxone and electroacunpunture (EA) improve the immune function of traumatized rats. Sheng Li Xue Bao 1998;50(6):636-42.

[47]. Hong Y, Lirong Y, Huifang M et Al. [Effects of acupuncture on the cellular immune function of the rat under stress state]. Acupuncture Research 2002;27(3):211

[48]. Zhao H, Du LN, Jiang JW, Wu GC, Cao XD. Neuroimmunal regulation of electroacupuncture (EA) on the traumatic rats. Acupunct Electrother Res 2002;27(1):15-27.

[49]. Yun SJ, Park HJ, Yeom MJ, Hahm DH, Lee HJ, Lee EH. Effect of electroacupuncture on the stress-induced changes in brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 2002;318(2):85-8.

[50]. Liang J, Lu J, Cui SF, Wang JR, Tu Y. [Effect of acupuncture on expression of brain-derived neurotrophic factor gene and protein in frontal cortex and hippocampus of depression rats]. Zhen Ci Yan Jiu. 2012;37(1):20-4.

[51]. Lim S, Ryu YH, Kim ST, Hong MS, Park HJ. Acupuncture increases neuropeptide Y expression in hippocampus of maternally-separated rats. Neurosci Lett 2003;343(1):49-52.

[52]. Park H, Yoo D, Kwon S, Yoo TW, Park HJ, Hahm DH, Lee H, Kim ST. Acupuncture stimulation at HT7 alleviates depression-induced behavioral changes via regulation of the serotonin system in the prefrontal cortex of maternally-separated rat pups. J Physiol Sci. 2012;62(4):351-7.

[53]. Park HJ, Chae Y, Jang J, Shim I, Lee H, Lim S. The effect of acupuncture on anxiety and neuropeptide Y expression in the basolateral amygdala of maternally separated rats. Neurosci Lett 2005;377(3):179-84.

[54]. Lee B, Shim I, Lee HJ, Yang Y, Hahm DH. Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci Lett. 2009;453(3):151-6.

[55]. Liu Q, Yu J, Mi WL, Mao-Ying QL, Yang R, Wang YQ, Wu GC. Electroacupuncture attenuates the decrease of hippocampal progenitor cell proliferation in the adult rats exposed to chronic unpredictable stress. Life Sci. 2007 Nov 10;81(21-22):1489-95.

[56]. Han YJ, Li WX, Jia BH, Shi YJ, Tu Y. [Effect of electroacupuncture on hippocampal NO-cGMP signaling pathway in depression rats]. Zhen Ci Yan Jiu. 2009;34(4):236-41.

[57]. Bao WY, Jiao S, Lu J, Tu Y, Song YZ, Wu Q, A YG. [Effect of electroacupuncture intervention on learning-memory ability and injured hippocampal neurons in depression rats]. Zhen Ci Yan Jiu. 2014;39(2):136-41.

[58]. Yang L, Yue N, Zhu X, Han Q, Liu Q, Yu J, Wu G. Electroacupuncture upregulates ERK signaling pathways and promotes adult hippocampal neural progenitors proliferation in a rat model of depression. BMC Complement Altern Med. 2013;13:288.

[59]. Hou LQ, Liu S, Xiong KR. [Effects of electroacupuncture on hippocampal nNOS expression in rats of post-traumatic stress disorder model]. Zhongguo Zhen Jiu. 2013;33(7):632-6.

[60]. Xu S, Li S, Shen X, Meng X, Lao L. Effects of electroacupuncture on depression in a rat model. Acupunct Electrother Res. 2011;36(3-4):259-73.

[61]. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC. Glia atrophy in the hippocampus of chronic unpredictable stress-induced depression model rats is reversed by electroacupuncture treatment. J Affect Disord. 2011;128(3):309-13.

[62]. Jiang LH, Wang LL. [Gene chips-aided analysis on the profiles of hippocampal whole-genome expression in depression rats following electroacupuncture treatment]. Zhen Ci Yan Jiu. 2010;35(2):83-9.

[63]. Xu SF, Zhuang LX, Tang CZ, Yang JJ. [Effects of acupuncture and embedding thread on central monoamine neurotransmitters in the depression model rat]. Zhongguo Zhen Jiu. 2007;27(6):435-7.

[64]. Zhu Y, Liu QY, Zhuo LS. [Influence of electroacupuncture of "Baihui" (GV 20) and "Sanyinjiao" (SP 6) on hippocampal 5-HT and AChE immuno-activity in chronic depression rats]. Zhen Ci Yan Jiu. 2009;34(1):16-20.

[65]. Yano T, Kato B, Fukuda F, Shinbara H, Yoshimoto K, Ozaki A, Kuriyama K. Alterations in the function of cerebral dopaminergic and serotonergic systems following electroacupuncture and moxibustion applications: possible correlates with their antistress and psychosomatic actions. Neurochem Res. 2004;29(1):283-93.

[66]. Yang CH, Lee BB, Jung HS, Shim I, Roh PU, Golden GT. Effect of electroacupuncture on response to immobilization stress. Pharmacol Biochem Behav 2002;72(4):847-55.

[67]. Kwon S, Kim D, Park H, Yoo D, Park HJ, Hahm DH, Lee H, Kim ST. Prefrontal-limbic change in dopamine turnover by acupuncture in maternally separated rat pups. Neurochem Res. 2012;37(10):2092-8.

[68]. Iwa M, Nakade Y, Pappas TN, Takahashi T. Electroacupuncture improves restraint stress-induced delay of gastric emptying via central glutaminergic pathways in conscious rats. Neurosci Lett. 2006;399(1-2):6-10.

[69]. Yu LL, Liu RP, Gao XY, Liu K, Li L, Ben H, Rong PJ. [Development of studies on neurochemical mechanism of acupuncture underlying improvement of depression]. Zhen Ci Yan Jiu. 2011;36(5):383-7.

[70]. Hu L, Liang J, Jin SY, Han YJ, Lu J, Tu Y. [Progress of researches on mechanisms of acupuncture underlying improvement of depression in the past five years]. Zhen Ci Yan Jiu. 2013;38(3):253-8.

[71]. Yao HJ, Song HT, Mo YP, Zhang TT, Han XB, Li ZG. [Effects of electroacupuncture on circadian rhythm of temperature and melatonin in depression rats model induced by chronic stress]. Zhongguo Zhen Jiu. 2014;34(7):685-9.

[72]. Bosco Guerreiro da Silva J. Acupuncture for mild to moderate emotional complaints in pregnancy--a prospective, quasi-randomised, controlled study. Acupunct Med. 2007;25(3):65-71.

[73]. Dennis CL, Dowswell T. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev. 2013;7:CD006795. doi: 10.1002/14651858.CD006795.pub3.

[74]. Sniezek DP, Siddiqui IJ. Acupuncture for Treating Anxiety and Depression in Women: A Clinical Systematic Review. Medical Acupuncture. 2013;25(3):164-172.

[75]. Manber R, Schnyer RN, Allen JJ, Rush AJ, Blasey CM. Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord. 2004;83(1):89-95.

[76]. Manber R, Schnyer RN, Lyell D, Chambers AS, Caughey AB, Druzin M, Carlyle E, Celio C, Gress JL, Huang MI, Kalista T, Martin-Okada R, Allen JJ. Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol. 2010;115(3):511-20.

[77]. Centre de Référence sur les Agents Tératogènes (CRAT). [cité le 30 mai 2015]. Available from URL : http://www.lecrat.org/sommaireFR.php3

[78]. HAS. Niveau de preuve et gradation des recommandations de bonne pratique - État des lieux. 2013. [cité le 04/12/2014]. Available from URL : http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-06/etat_des_lieux_niveau_preuve_gradation.pdf.